This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Penn State Research Foundation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Linda M Cruz: Innovator in Nontoxic Compounds for Virus Treatment
Introduction
Linda M Cruz is a notable inventor based in Elizabethtown, PA (US). She has made significant contributions to the field of virology through her innovative research and development of nontoxic compounds aimed at treating and preventing herpesvirus infections. Her work is crucial in the ongoing battle against viral diseases.
Latest Patents
Linda holds a patent for her invention titled "Nontoxic compounds for the treatment and prevention of herpesvirus infections." This patent focuses on compositions that inhibit the biogenesis of cytoplasmic viral assembly compartments (cVAC). The preferred compounds identified in her research are dihydroquinazolinones, which show promise in combating viral infections effectively.
Career Highlights
Linda is affiliated with the Penn State Research Foundation, where she continues to advance her research in virology. Her dedication to developing safe and effective treatments for viral infections has positioned her as a key figure in her field. With a patent portfolio that includes 1 patent, she exemplifies the spirit of innovation and scientific inquiry.
Collaborations
Throughout her career, Linda has collaborated with esteemed colleagues, including Nicholas J Buchkovich and Dhimant H Desai. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in the treatment of viral infections.
Conclusion
Linda M Cruz is a pioneering inventor whose work in developing nontoxic compounds for the treatment of herpesvirus infections is making a significant impact in the field of virology. Her contributions are vital in the search for effective antiviral therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
